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Abstract 0 The dissolution of powder drugs, besides being a topic of
utmost importance, especially for the sparingly soluble ones, is far from
being well-explained. The purpose of the present study is, on the one
hand, to obtain experimental dissolution profiles and, on the other hand,
to analyze and process the data for dissolution modeling. Three different
size fractions of a widely used sparingly soluble drugsibuprofenswere
fully characterized with regard to its particle size distribution, specific
surface area, density, solubility, and diffusion coefficient. The dissolution
profiles were obtained making use of a technique that counts and sizes
particlessthe Coulter counter techniqueswhich is capable of following
the number and size of the particles in suspension throughout time. The
knowledge of these parameters allowed a critical study of the assumptions
associated with the models currently used to describe the dissolution
process. It was concluded that most of the assumptions were not valid
for the present experimental conditions. This motivated the proposal of
a new methodology, which uses the experimentally determined charac-
teristics of the drug and takes into account the polydisperse nature of
the powder. By applying an adequate dissolution equation to each of
the many size classes in which the primary particle size distribution was
divided, it was possible to obtain a large agreement between the simulated
and the experimental dissolution profile.
Introduction
Dissolution tests of powdered drugs are currently used for
drug characterization. Although they are mostly utilized as
quality control methods (to ensure end product quality or
batch to batch consistency), they may also be correlated to in
vivo activity. In fact, it is now well-recognized that the rate
of dissolution often controls the drug bioavailability, in
particular for poorly soluble drugs where dissolution is the
rate-limiting step. Numerous examples can be found in
pharmaceutical literature illustrating the critical importance
of dissolution kinetics on the extent and rate of drug absorp-
tion.1,2 However, to manipulate the bioavailability of the
administered drug, a full understanding of the dissolution
phenomenon is crucial. Nevertheless, despite the proposal of
various models to describe the release kinetics of sparingly
soluble drugs,3,4 no general agreement has yet been found to
interpret dissolution data.
Earlier studies, undertaken to investigate the influence of
particle size on the dissolution rate of indomethacin,5,6
revealed that the classical dissolution models did not ad-
equately explain the experimentally obtained dissolution
profiles. These were fully discussed regarding their ap-
plicability and associated assumptions.
The emphasis of the present work is on the development of
a mathematical procedure which takes into account the
polydisperse nature of the powder and the variation of the
particle number throughout dissolution, factors which have
not been contemplated in the classical models. Furthermore,
this method also intends to be applicable to distinct size
ranges. For this, three different size fractions of ibuprofen
were dissolution tested and the corresponding experimental
dissolution profiles were compared with the simulated ones.
All the steps of this procedure will be described in detail.
Theoretical
Many theoretical models have been proposed to characterize
the dissolution mechanism of multiparticulate systems since
the first equation presented by Noyes and Whitney in 1897.7
Most models assume quasi-steady-state diffusion and are
based on the following equation:8,9
where W ) dissolved solids weight, t ) time, D ) diffusion
coefficient, h ) diffusion layer thickness, S ) interfacial area,
CS ) solubility, and C ) dissolved concentration.
The so-called classical diffusional models result from the
integration of eq 1 supposing that the diffusion coefficient is
independent of concentration and time and the particle shape
nearly spherical. Particle monodispersity is assumed and
therefore the interfacial area is easily related to the solids
weight (S is proportional to w2/3), considering a constant
particle number. The fundamental differences between these
models rely upon the interdependency between the diffusion
layer thickness (h) and particle size (d). Indeed, while some
authors, like Hixson and Crowell,10 for example, assume h to
be a constant, others considered h to be proportional to the
particle diametersapproximately equal to the particle radius,
like Higuchi and Hiestand,11 or its square root, like Niebergall
et al.12 Different algebraic relations between h and d result,
obviously, in different equations for the integrated form of eq
1. These equations, together with the associated assumptions
regarding the value of h and the corresponding dissolution
rate constants are presented in Table 1.
Despite the wide variation of the power to whichw is raised
(eqs 2-4), good agreements have been reported for either
model. An explanation for this can probably be found in a
more detailed analysis of the assumptions made for each
model. For instance, it has been shown that eq 2 describes
the dissolution kinetics of large particles well,10 whereas, for
the smaller ones, good agreements have been found using eqX Abstract published in Advance ACS Abstracts, May 1, 1997.
Table 1sClassical Dissolution Modelsa
h Integrated Equation Rate Dissolution Constant eq
constant w0
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3N
1/3D
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a k ) constant, d ) particle diameter, N) particle number, w0 ) suspended
solids weight at time t ) 0, and w ) suspended solids weight at time t ) t.
dW
dt
) D
h
S(CS - C) (1)
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3.11,13 Moreover, and especially for the fine particles, a size
(and time) dependent diffusion layer thickness seems a more
realistic approach than a constant value of h over the particle
lifetime. However, Hintz and Johnson14 and Lu et al.,15 among
other authors, postulate that h varies linearly with d up to a
certain value, beyond which h remains unaltered. This
assumption encompasses the differences in the release kinet-
ics reported above for both small and large particles.
Nevertheless, in a previous work,6 some of the present
authors have shown that probably more important than the
relationship between h and d is the validity of the other
assumptions implicit in the models. Indeed, taking into
account factors, like the change in the number of suspended
particles throughout dissolution, their departure from sphe-
ricity, or the polydispersity degree, can result in a significant
improvement in the model fitting. Some of these factors
(although separately) have already been discussed by other
authors.11,16-18 However, most of these studies are math-
ematically complex and assume that the particle size distribu-
tion follows a log-normal law which, in many cases, repre-
sents an oversimplification.
The methodology adopted here intends to be generally
applicable, i.e., valid for any particle size distribution following
any dissolution equation, and, in addition, mathematically
simple. It consists of dividing the primary particle size
distribution into a large number of classes so that the particles
in each size class could be considered monosized, in accordance
with the assumptions of the dissolution models. Although the
particle analyzer utilized (Coulter Multisizer II) can distribute
the particles in 64, 128, and 256 size classes (channels), only
64 classes were used, since no improvements were detected
in the fittings using a larger number of classes. In this way,
significant computing time was saved. The next step was to
choose between a size dependent on or independent of diffu-
sion layer thickness, and the consequent dissolution equation.
The first choice was to assume a linear relationship between
h and d (eq 3). That had already been suggested in previous
studies6,19 and has more physical meaning. Nevertheless this
model was not found to be adequate for the coarsest fraction,
as will be described later. In this case, a better fit was
achieved considering a constant value for h, above a certain
particle size (dcrit). This is in agreement with the authors who
suggest that h does not always increase with particle size but
reaches a plateau at some critical value.14,15
With this in mind, a Fortran 77 program was written, the
flowchart of which is presented in Figure 1. From the initial
Figure 1sFlowchart of the program.
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data supplied by the Coulter Multisizer, which is basically
the number of particles per size class (Ni), the weight of solids
in each class is calculated according to
where Ni ) number of particles in size class i, F ) solids
density, di ) mean diameter of size class i, andw0,i ) particles
weight at time t ) 0 for size class i.
It should be emphasized that the diameter given by the
Coulter gives a volume-based diameter [dv ) (6v/ð)1/3, v being
the particle volume directly measured by the Coulter]. Hence,
eq 5 is an accurate expression even for nonspherical particles.
Depending on di, the following dissolution equations were
used to calculate the solids weight decrease
and
where wt+¢t,i ) suspended particles weight at time t + ¢t for
size class i, k ) constant (see Table 1), Rs,dv ) particle shape
factor, and dcrit ) critical diameter.
It should be noted that eqs 6 and 7 are similar to eqs 3 and
2, respectively. The only difference is the experimental
particle shape factor (Rs,dv) used instead of ð (only valid for
spheres).
The time interval utilized in the calculations (¢t) was small,
typically 1 s, in order to ensure a constantNi, which is another
requirement of the classical models. After each time interval,
a new value of di was calculated according to
Whenever di became smaller than the minimum detectable
by the Coulter, dmin ((2% of the aperture tube), the particles
in this class were considered completely dissolved. That leads,
obviously, to a decrease in the overall particle number. A tmax
was user-defined and read as data.
The total weight of suspended solids can be estimated at
any time value as the summation of the weights calculated
for each size class. The dissolution profiles obtained in this
way could then be compared to the experimental ones in order
to optimize the values of k ()h/d) and dcrit, as will be discussed
in a subsequent section.
Experimental Section
Ibuprofen was the drug selected for this study because it is a widely
used NSAID that is sparingly soluble at low pH. Since one of the
objectives was to test the applicability of the dissolution models to
different size ranges, fractions of nominal sizes 25, 38, and 50 ím
were utilized. These fractions, used as supplied, were fully character-
ized with respect to particle size distribution, solubility, diffusion
coefficient, specific surface area, and density. Differential scanning
calorimetry was also utilized to guarantee that all the fractions
corresponded to the same racemic mixture of (+)- and (-)-enant-
eomers.
Physical Characterization of Ibuprofen FractionssThe pri-
mary particle size distribution of all fractions was determined using
the Coulter Multisizer II. This apparatus counts and sizes particles
suspended in an electrolyte according to the electrical sensing zone
method.20 This method is largely used in particle size characteriza-
tion21 and has recently been successfully applied to dissolution studies
of pharmaceutical powders.5,22 It provides dynamic information not
only on the particle number and size distribution but also on the
concentration of suspended solids, enabling the evaluation of dissolu-
tion profiles.
This technique requires a previous calibration of the apparatus,
which is normally performed with latex spheres of known size.
However, the primary calibration procedure recommends the use of
the particles under analysis.23 This procedure, often known as self-
calibration, was the one followed in this work. Although more
laborious than latex calibration, self-calibration is more accurate since
it accounts for the particle properties (e.g. shape, conductivity, and
porosity).24
In order to determine the primary size distribution, and in spite
of the low solubility of ibuprofen, the particles were suspended in
previously saturated drug solutions. A 100 ím aperture tube was
employed for the experiments with the 25 and 38 ím fractions, while
for the 50 ím fraction, a 200 ím tube was used. All the experiments
were carried out at least four times.
In order to transform the weight of the particles in surface area,
without assuming any specific particle shape, it is necessary to
determine the particle shape factor, Rs,dv.20 This requires the
knowledge of the powder specific surface area,25 which in turn was
estimated by the BET method in the ASAP 2000 from Micromeritics,
using krypton as adsorbate.26
As the Coulter Multisizer output is given in terms of the volume
of the solids and eq 1 utilizes the solids’ weight, it is necessary to
convert volume into weight (or mass) using for that the true density
of the material. This was measured by helium pycnometry in the
Accupyc from Micromeritics.26
The diffusion coefficient was evaluated using the rotating disk
method.27 Disks were prepared by compressing 300 mg of ibuprofen
with a hydraulic press, in a 13 mm diameter die, applying a pressure
of 1 ton during 1 min. The disks were inserted in a special device in
which only one face is exposed to the solvent. The rotating speed
was 100 rpm. During the dissolution process, the liquid was forced
to pass through a spectrophotometer that automatically monitored
the fluid absorbence.
The ibuprofen solubility was determined by spectrophotometric
assay at 221 nm of ibuprofen saturated solutions. These were
prepared by dispersing an ibuprofen excess of about 3 times the
solubility on the dissolution medium.
Both the diffusion coefficient and the solubility measurements were
performed in triplicate at 23 ( 1 °C.
Experimental Dissolution ProfilessAs mentioned before, the
Coulter Multisizer II enables the dissolution process to be monitored
in terms of particle concentration. The amount of dissolved drug is
calculated from the difference between the initial particle concentra-
tion and that remaining at any instant of time, as described in detail
elsewhere.5 The suspending medium was potassium dihydrogen
phosphate buffer solution at pH ) 4.5,28 complemented with 0.01%
Tween 80 to facilitate solids dispersion. All tests were repeated, under
sink conditions, at least six times at room temperature (23 ( 1 °C).
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Figure 2sPrimary particle size distribution measured by the Coulter Multisizer II
for the ibuprofen fractions: (a) 25 ím, (b) 38 ím, and (c) 50 ím nominal size.
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Results and Discussion
Physical CharacterizationsFigure 2 shows the primary
size distribution of the three fractions of ibuprofen tested,
measured by the Coulter Multisizer II. As can be seen, the
fractions of nominal size 25 and 38 ím have very similar size
distributions, in spite of the different nominal sizes specified
by the supplier. The 50 ím fraction was found to be consider-
ably coarser. Besides, and as will be more clearly shown in
Figure 6, this fraction is much broader than the other two.
The corresponding volume median diameters (d50) are listed
in Table 2 together with the remaining characteristics of the
fractions determined, as described earlier. The values ob-
tained for the diffusion coefficient, solubility, and density are
approximately the same, regardless of the fraction size. On
the contrary, a decrease in the shape factor (Rs,dv) was noticed
as the fraction size increased. This was, somehow, unexpected
since the shape factor is normally size independent. However,
the fractions tested (used as supplied) may not have been
produced exactly in the same conditions and this could be
responsible for the encountered differences in Rs,dv.
Dissolution ProfilessThe dissolution profiles are dis-
played in Figure 3 for the different ibuprofen fractions. As
expected, a strong influence of the initial particle size was
detected. The curves corresponding to the 25 and 38 ím
fractions are approximately the same, most certainly due to
the similarity of both size distributions. On the other hand,
a much slower release was found for the coarsest fraction.
The dissolution data was treated according to eqs 2 and 3,
and the results are presented in Figure 4. As this figure
shows, no significant improvements were found by using
different models. In fact, in both cases, a nonlinear tendency
of the experimental profiles was observed, which is more
noticeable for the coarsest fraction. As the two models only
differ in the relationship between the diffusion layer thickness
and particle size, it can be concluded that this is not, at least
exclusively, the only reason for the lack of fitting. However,
it should be remembered that these models have other implicit
assumptions, namely particle sphericity, constant particle
number throughout dissolution, and monodispersity. A care-
ful examination of the validity of these assumptions led to
the following conclusions:
(1) The experimentally determined shape factors (Table 2)
indicate that the ibuprofen particles are not very far from
spherical (Rs,dv ) ð for spheres), the lowest value correspond-
ing to the coarsest fraction.
(2) As for the total particle number (N), Figure 5 shows that
there is a continuous decrease of this parameter from the very
beginning of dissolution, for all size fractions.
(3) As illustrated in Figure 6 and previously in Figure 2,
the particles in each fraction are not monosized, fraction 50
being considerably broader than the remaining fractions.
Furthermore, Figure 6 shows that, for example, the size
distribution of fraction 50 is better approximated by a normal
rather than by a log-normal distribution, frequently assumed
by a number of authors.11,15-18
From these findings, it can be concluded that at least some
of the model-associated assumptions are not fulfilled, which
may explain the encountered discrepancies when trying to fit
the classical models to the experimental data. Moreover, the
higher deviations found for the coarsest fraction (Figure 4)
are most certainly due to the broadness of its size distribution,
confirming the need to account for this aspect.
As an attempt to overcome this problem, and as described
in section 2, a methodology was developed which takes into
account the change in particle number and the polydisperse
nature of the powder. Additionally, it uses the real particle
shape factor and does not require the particles to follow any
specific size distribution law. A preliminary simulated dis-
solution profile was evaluated using the primary particle size
distribution of fraction 25 and the parameters of Table 1.
Equation 6 was the one selected with a value of k ) 0.5 (h is
equal to the particle radius) as suggested by Higuchi and
Hiestand.11 Although a similar trend was obtained for the
Table 2sPhysical Characteristics of Ibuprofen Samplesa
Fraction
Nominal
Size, ím
Volume
Median
Diameter
(d50), ím
Shape
Factor
(Rs,dv)
Solubility
(Cs),
íg/mL
Diffusion
Coefficient
(D) × 106 cm2/s
Density
(F) g/cm3
25 22.9 ± 0.2 4.1 ± 0.1 73 ± 1.7 6.54 ± 0.04 1.11 ± 0.01
38 27.3 ± 0.4 3.6 ± 0.2 73 ± 1.3 6.65 ± 0.17 1.11 ± 0.01
50 52.6 ± 0.3 3.2 ± 0.1 71 ± 1.7 6.55 ± 0.08 1.11 ± 0.01
a Average values ± standard deviation.
Figure 3sDissolution profiles obtained with the Coulter Multisizer II. (Error bars
represent the standard deviation of a mean of six experiments.)
Figure 4sApplication of the (a) Hixson−Crowell model (eq 2) and the (b) Higuchi-Hiestand model (eq 3) to the experimental dissolution profiles.
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simulated and the experimental profiles, these did not exactly
overlap (data not shown). That could only be achieved using
another value of k. The best fit (quantified by the mean
residue, Rh , and maximum residue, Rmax29) gave a value k )
0.28 (Figure 7), which corresponds to a value of h that is
approximately half of the particle radius. Values of k different
from 0.5 were also reported by Mauger et al.13 for the
dissolution of particles of prednisolone acetate. It should be
outlined, however, that the exact value of k is normally
unknown.
Nevertheless, when a value of k ) 0.28 was used to simulate
the kinetics release of the other fractions, a discrepancy was
noticed for the coarsest fraction, as illustrated in Figure 7. A
good agreement was only obtained when introducing the
condition that, whenever the particle size reached some
critical value (dcrit), h would remain constant ()kdcrit) and eq
7 should be used instead of eq 6 (see flowchart, Figure 1). A
large agreement was, then, obtained for all fractions as Figure
8 shows, with dcrit ) 22 ím and k ) 0.26 (quite close to the
previous value). Furthermore, the fact of these agreements
are observed over the entire dissolution profile substantiates
the reliability of the above assumptions.
Since no more samples of ibuprofen were available, and in
order to test the capability of the program to predict the
dissolution profiles of broader distributions (which seems to
be a major cause for the lack of fit), additional experiments
were carried out using mixtures of the finest and coarsest
fractions. As can be seen from Figure 9, equally good fittings
were obtained, which confirms the adequacy of the model to
predict dissolution profiles based only on the primary particle
size distributions (once the drug characteristics are known).
Conclusions
This study has demonstrated that the main reason for the
inadequacy of the classical dissolution models to predict the
release kinetics of the ibuprofen fractions is due to the
assumptions associated with these models not being valid for
the case of multisized powders. This conclusion was made
possible by the Coulter Multisizer, which counts and sizes the
suspended particles as a function of time. Furthermore, the
utilization of the Coulter Multisizer for dissolution studies is
extremely convenient since, with a single technique, it is
possible to obtain the number and size distribution of the
particles in suspension at any instant and, simultaneously,
to determine the absolute concentration of the solids. The
drug dissolution profile can be easily evaluated from the latter.
Thus, it was possible to prove that the number of particles
in suspension continuously diminishes as dissolution proceeds,
contrary to the constant value assumed by the models.
Figure 5sParticle number variation during dissolution expressed as a percentage
of the initial number (N0).
Figure 6sMass cumulative size distributions of the primary ibuprofen fractions plotted on (a) log−normal and (b) normal probability paper.
Figure 7sExperimental versus simulated (k ) 0.28) dissolution profiles of the various ibuprofen fractions: fraction 25, Rh ) 0.012 and Rmax ) 0.02129; fraction 38,
Rh ) 0.016 and Rmax ) 0.034; fraction 50, Rh ) 0.142 and Rmax ) 0.206.
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Besides, it was apparent from the measured size distributions
(and despite the analyzed fractions being relatively narrow)
that these were far from monodisperse, another of the
conditions assumed by the classical models.
The strategy adopted in this work was to divide the primary
particle size distribution of the fraction under study into a
large number of size classes, so that the particles in each class
could be considered monodisperse. A dissolution kinetics
equation was then applied to every class, and the calculated
dissolution profiles compared to those obtained experimen-
tally. This procedure enabled the choice of the most adequate
dissolution law.
Although previous studies had indicated that the equations
based on a size dependent diffusion layer thickness would be
more adequate, it was found out that a single dissolution
equation was not able to describe the release profiles for all
the size ranges tested. As a matter of fact, the use of a
constant diffusion layer model, above a given particle size,
greatly improved the fitting between the model and the
experimental data for the coarsest fraction. Both the propor-
tionality constant between the boundary layer thickness and
particle size (k) and the critical particle diameter (dcrit) were
optimized from the experimental dissolution profiles. The
remarkably good agreements between the simulated and the
experimental data over the entire dissolution profile, for all
size fractions, suggest that the assumptions made are physi-
cally realistic.
In conclusion, the methodology now proposed to predict the
dissolution of ibuprofen has proved to be accurate and
mathematically straightforward, requiring, basically, the
primary characteristics of the powdered drug. Additionally,
the use of the real particle size distribution and shape factor
represents a great advantage over the procedures which
assume these parameters. Indeed, nowadays, with so many
accessible sizing techniques, there is no need to approximate
the drug particle size distribution to a predetermined law.
In summary, it is believed that this approach is most
promising to predict dissolution profiles, its strongest point
being the fact that it could eventually be applicable to virtually
all multisized powder drugs. Further experiments with other
sparingly soluble drugs are necessary to demonstrate its
general applicability.
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